These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 21160410)

  • 41. Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.
    Anderson AM; Lennox JL; Mulligan MM; Loring DW; Zetterberg H; Blennow K; Kessing C; Koneru R; Easley K; Tyor WR
    J Neurovirol; 2017 Feb; 23(1):106-112. PubMed ID: 27400930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnosis and clinical features of major neuropsychiatric disorders in HIV infection.
    Gallego L; Barreiro P; López-Ibor JJ
    AIDS Rev; 2011; 13(3):171-9. PubMed ID: 21799535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Are MMSE and HDS-R neuropsychological tests adequate for screening HIV-associated neurocognitive disorders?
    Nakazato A; Tominaga D; Tasato D; Miyagi K; Nakamura H; Haranaga S; Higa F; Tateyama M; Fujita J
    J Infect Chemother; 2014 Mar; 20(3):217-9. PubMed ID: 24462448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?
    Vassallo M; Durant J; Biscay V; Lebrun-Frenay C; Dunais B; Laffon M; Harvey-Langton A; Cottalorda J; Ticchioni M; Carsenti H; Pradier C; Dellamonica P
    AIDS; 2014 Feb; 28(4):493-501. PubMed ID: 24472743
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurologic complications of HIV infection.
    Spudich SS; Ances BM
    Top Antivir Med; 2012; 20(2):41-7. PubMed ID: 22710906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. What's in a name? AIDS dementia complex, HIV-associated dementia, HIV-associated neurocognitive disorder or HIV encephalopathy.
    Singh D
    Afr J Psychiatry (Johannesbg); 2012 May; 15(3):172-5. PubMed ID: 22722724
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HIV, dementia and antiretroviral drugs: 30 years of an epidemic.
    Manji H; Jäger HR; Winston A
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1126-37. PubMed ID: 23378642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [NeuroAIDS].
    Nakagawa M; Kondo M
    Nihon Rinsho; 2010 Mar; 68(3):502-7. PubMed ID: 20229798
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Symptomatic cerebrospinal fluid escape.
    Mastrangelo A; Turrini F; de Zan V; Caccia R; Gerevini S; Cinque P
    AIDS; 2019 Dec; 33 Suppl 2():S159-S169. PubMed ID: 31789816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuropathology of HAND With Suppressive Antiretroviral Therapy: Encephalitis and Neurodegeneration Reconsidered.
    Gelman BB
    Curr HIV/AIDS Rep; 2015 Jun; 12(2):272-9. PubMed ID: 25860316
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment.
    Chan P; Brew BJ
    Curr HIV/AIDS Rep; 2014 Sep; 11(3):317-24. PubMed ID: 24966139
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of hydroxyurea in plasma and cerebrospinal fluid of HIV-1-infected patients.
    Gwilt PR; Manouilov KK; McNabb J; Swindells SS
    J Clin Pharmacol; 2003 Sep; 43(9):1003-7. PubMed ID: 12971033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Dementia associated with AIDS].
    Casanova-Sotolongo P; Casanova-Carrillo P; Casanova-Carrillo C
    Rev Neurol; 2002 Apr 16-30; 34(8):781-7. PubMed ID: 12080499
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong - a single center study.
    Chan FCC; Chan P; Chan I; Chan A; Tang THC; Lam W; Fong WC; Lee MP; Li P; Chan GHF
    BMC Infect Dis; 2019 Feb; 19(1):156. PubMed ID: 30760220
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contemporary trends in HIV-associated neurocognitive disorders in Ghana.
    Sarfo FS; Kyem G; Asibey SO; Tagge R; Ovbiagele B
    Clin Neurol Neurosurg; 2021 Nov; 210():107003. PubMed ID: 34715557
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [HIV associated neurocognitive disorders].
    Bragança M; Palha A
    Actas Esp Psiquiatr; 2011; 39(6):374-83. PubMed ID: 22127910
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PET brain imaging in HIV-associated neurocognitive disorders (HAND) in the era of combination antiretroviral therapy.
    Vera JH; Ridha B; Gilleece Y; Amlani A; Thorburn P; Dizdarevic S
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):895-902. PubMed ID: 28058461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Three-decade neurological and neurocognitive follow-up of HIV-1-infected patients on best-available antiretroviral therapy in Finland.
    Heikinheimo T; Poutiainen E; Salonen O; Elovaara I; Ristola M
    BMJ Open; 2015 Nov; 5(11):e007986. PubMed ID: 26546135
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changing clinical phenotypes of HIV-associated neurocognitive disorders.
    Sacktor N
    J Neurovirol; 2018 Apr; 24(2):141-145. PubMed ID: 28752495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [HIV 1-associated neurocognitive disorder: current epidemiology, pathogenesis, diagnosis and management].
    Eggers C;
    Nervenarzt; 2014 Oct; 85(10):1280-90. PubMed ID: 25292163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.